Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Income from Continuing Operations (2016 - 2025)

Avanos Medical (AVNS) has disclosed Income from Continuing Operations for 13 consecutive years, with 1300000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 99.67% to 1300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 72900000.0 through Dec 2025, up 81.13% year-over-year, with the annual reading at 72900000.0 for FY2025, 81.13% up from the prior year.
  • Income from Continuing Operations hit 1300000.0 in Q4 2025 for Avanos Medical, up from 1400000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 38500000.0 in Q2 2021 to a low of 397000000.0 in Q4 2024.
  • Historically, Income from Continuing Operations has averaged 23455000.0 across 5 years, with a median of 400000.0 in 2024.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 1383.33% in 2021 and later plummeted 3709.09% in 2024.
  • Year by year, Income from Continuing Operations stood at 25700000.0 in 2021, then surged by 137.74% to 9700000.0 in 2022, then rose by 13.4% to 11000000.0 in 2023, then tumbled by 3709.09% to 397000000.0 in 2024, then surged by 99.67% to 1300000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for AVNS at 1300000.0 in Q4 2025, 1400000.0 in Q3 2025, and 76800000.0 in Q2 2025.